From USD 922.5 million in 2019, The Global Flu Treatment Market is Predicted to Grow to USD 1,325.0 Million By 2025, Registering a CAGR of 5.3% During the Forecast Period (2020–2025): VynZ Research

Industry Insights by Type (Type A, Type B, Type C), by Route of Administration (Oral, Parenteral, Others), by Medication (Analgesics, Antiviral Drugs, Antihistamines, Others), by End User (Hospitals, Specialty Clinics, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)


NEW YORK, May 05, 2020 (GLOBE NEWSWIRE) -- From USD 922.5 million in 2019, the global flu treatment market is predicted to grow to USD 1,325.0 million by 2025, registering a CAGR of 5.3% during the forecast period (2020–2025). An excessive innovation undertaken by the key manufacturers of drug is the key trends observed in the growth of global flu treatment market. Rapid innovations and research assignments are being massively undertaken in order to combat COVID-19 situation globally.  This innovation is out most important in the situation where corona virus is at peak globally and is further expected to prevail for which vital treatments is to be implemented as soon as possible as human life is endangered in the present scenario. As a result, to this innovation in drugs global flu treatment market is expected to witness positive growth.

Get a free copy of sample report: https://www.vynzresearch.com/healthcare/global-flu-treatment-market/request-sample

The hospital pharmacy segment is expected to witness highest CAGR during the forecast period in the global flu treatment market

On the basis of distribution channel, the global flu treatment market is classified into hospital pharmacy, retail pharmacy, and others. Amongst these segments, hospital pharmacy is expected to witness highest CAGR during the forecast period as the large numbers of patients across the globe are suffering from COVID-19 crisis that is further accentuating the global flu treatment market.

Explore key industry insights in 76 tables and 45 figures from the 191 pages of report, “Global Flu Treatment Market Analysis and Forecast to 2025 - Industry Insights By Type (Type A, Type B, Type C), by Route of Administration (Oral, Parenteral, Others), by Medication (Analgesics, Antiviral Drugs, Antihistamines, Others), by End User (Hospitals, Specialty Clinics, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)”

Geography Insight

Geographically, Europe was the largest flu treatment market in 2019. This is owing to the massive outbreak of COVID-19 in the region. According to a report published by European Union, approximately 1,563,857 cases of COVID-19 has been discovered in Europe till first week of April and total deaths registered in the region were 95,044. As a result to this the demand for developing vaccines is out most important in order to reduce the death counts and those affected by the virus.

The Asia-Pacific flu treatment market is projected to witness fastest growth in the global flu treatment market during the forecast period, owing to the outbreak of COVID-19 in countries such as India that has recently exploded in the country, and also in China where the origin of COVID-19 patients occurred.

Competitive Insight

Some of the key players operating in the global flu treatment market are GlaxoSmithKline plc, AstraZeneca, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, NATCO Pharma Limited, Merck & Co., F. Hoffmann-La Roche Ltd, Inc., Bayer AG, Mylan N.V., Pfizer Inc., and Sanofi.

Do you have any specific research requirement? Ask for customization: https://www.vynzresearch.com/healthcare/global-flu-treatment-market/customize-report

Global Flu Treatment Market Coverage

Type Insight and Forecast 2015 – 2025

  • Type A
  • Type B
  • Type C

Route of Administration Insight and Forecast 2015 – 2025

  • Oral
  • Parenteral
  • Others

Medication Insight and Forecast 2015 – 2025

  • Analgesics
  • Antiviral Drugs
  • Antihistamines
  • Others

End User Insight and Forecast 2015 – 2025

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel Insight and Forecast 2015 – 2025

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Geographical Segmentation

Flu Treatment Market by Region

North America

  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – U.S., Canada, and Mexico

Europe

  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – China, Japan, India, Australia, Singapore, South Korea, Indonesia, and Rest of Asia-Pacific

Rest of the World (RoW)

  • By Type
  • By Route of Administration
  • By Medication
  • By End User
  • By Distribution Channel
  • By Country – Brazil, Argentina, South Africa, Saudi Arabia, Iran, U.A.E., and Other Countries

More from VynZ Research

Global Isolation Beds Market Analysis and Forecast to 2025

The global isolation beds market is growing at a CAGR of 7.0% during the forecast period (2020–2025). The primary driver impacting the growth of the global isolation beds market is the rapid surge in infectious diseases across the globe. In recent times, several countries have witnessed outbreak of viral diseases such as severely acquired respiratory syndrome (SARS), E-Bola, H1N1 virus, and COVID 19 (coronavirus). The death rate of COVID-19 appears to be higher in comparison to normal seasonal flu, and it differs with respect to location. For instance, at the epicentre (Hubei province, China) the death rate was 2.9%, whereas at other provinces it was 0.4%.

India Isolation Beds Market Analysis and Forecast to 2025

The Indian isolation beds market size in terms of volume is estimated to be 308,519.0 units in 2020 and is predicted to reach 403,929.0 units by 2025, growing at a CAGR 5.5% during 2020 – 2025. The major factors driving the growth of the market is the increase in the number of coronavirus patient in the country. According to a website www.covid19india.org, the number of confirmed cases in India was 23,421, active cases was 17,598, and the number of recovered patients from coronavirus was 5,095 in April 24, 2020.

Global Medical Ventilator Market Analysis and Forecast to 2025

The global medical ventilator market is expected to grow at a CAGR of 8.5% during the forecast period 2020 – 2025. The demand for ventilators is expanding with the growing number of sick patients, coupled with the high growth of chronic sickness among kids, and the increasing lifestyle disorders. These are creating health issues such as respiratory diseases, and heart attacks, which are demand more medical ventilators across the globe.

Benefits of Report Purchase from VynZ:

We provide accurate data and in-depth analysis with all-inclusive coverage. We focus on robust research methodology and data triangulation to ensure high quality report. We believe in providing 24*7 analyst support to our client – Pre and post purchase of the report as well as during the project tenure.

We also offer 20% post purchase free customization in the study to meet your needs. Due. We claim full customer satisfaction as our core values lie in building long term relationship.

About VynZ Research

VynZ Research is a market research firm offering research, analytics, and consulting services on business strategies. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. VynZ Research assists enterprises to take strategic decisions for helping their businesses to grow. The reports developed by VynZ are based on market facts that includes comprehensive analysis and quantification of market drivers, industry dynamics, opportunities, challenges, threats, market shares and anticipated new trends & technologies arising across wide range of industries.

Contact Us:

VynZ Research

Call: +91-996-028-8381

Toll Free (U.S. and Canada): +1-888-253-3960

Email: enquiry@vynzresearch.com

Web: https://www.vynzresearch.com

Connect with Us: LinkedIn | Facebook | Twitter